Stockscreener 앱 받기
18.70
1.42%
-0.27
시간 외 거래:
18.55
-0.15
-0.80%
전일 마감가:
$18.97
열려 있는:
$18.82
하루 거래량:
331.34K
Relative Volume:
0.92
시가총액:
$130.02M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-11.40
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
-22.44%
1개월 성능:
-44.67%
6개월 성능:
+74.60%
1년 성능:
+12.10%
1일 변동 폭
$18.39
$19.95
1주일 범위
$18.39
$24.50
52주 변동 폭
$2.622
$65.80
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
18.70 | 130.02M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-09-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-07-26 | 개시 | Wedbush | Outperform |
| 2022-04-27 | 개시 | Goldman | Neutral |
| 2021-12-17 | 개시 | H.C. Wainwright | Buy |
| 2021-12-03 | 개시 | Robert W. Baird | Outperform |
| 2021-12-02 | 개시 | Oppenheimer | Outperform |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-03-03 | 개시 | Evercore ISI | Outperform |
| 2021-03-02 | 개시 | Goldman | Sell |
| 2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Can a trend reversal in Vor Biopharma Inc. lead to recovery2025 Dividend Review & Fast Momentum Stock Entry Tips - newser.com
How institutional ownership impacts Vor Biopharma Inc. stockQuarterly Portfolio Summary & AI Based Buy and Sell Signals - newser.com
Vor Bio (NASDAQ: VOR) joins TD Cowen, Evercore chats Nov. 12 and Dec. 2; webcasts - Stock Titan
Why Vor Biopharma Inc. stock could benefit from AI revolution2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Gap Down & Free Long-Term Investment Growth Plans - newser.com
Using Python tools to backtest Vor Biopharma Inc. strategies2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsPortfolio Performance Summary & Real-Time Sentiment Analysis - newser.com
Will Vor Biopharma Inc. stock gain from government policies2025 Pullback Review & AI Powered Market Trend Analysis - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.Wall Street Watch & Low Risk Entry Point Guides - newser.com
Forecasting Vor Biopharma Inc. price range with options data2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Can Vor Biopharma Inc. stock beat analyst upgradesEarnings Beat & Free Weekly Watchlist of Top Performers - newser.com
Pattern recognition hints at Vor Biopharma Inc. upside2025 Top Decliners & Consistent Return Investment Signals - newser.com
Vor Biopharma Inc. stock chart pattern explainedTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Technical signs of recovery in Vor Biopharma Inc.Weekly Risk Report & Safe Entry Momentum Tips - newser.com
Vor Biopharma Inc. stock retracement – recovery analysisWeekly Market Outlook & Accurate Technical Buy Alerts - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockQuarterly Market Summary & Expert Approved Momentum Ideas - newser.com
Is Vor Biopharma Inc. stock a buy before product launches2025 Earnings Impact & Safe Investment Capital Preservation Plans - fcp.pa.gov.br
Combining price and volume data for Vor Biopharma Inc.Gold Moves & Real-Time Chart Breakout Alerts - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsMarket Trend Review & Real-Time Market Sentiment Reports - newser.com
Is Vor Biopharma Inc. stock a top pick in earnings seasonForecast Cut & Reliable Price Action Trade Plans - fcp.pa.gov.br
Using data models to predict Vor Biopharma Inc. stock movementMarket Performance Summary & Accurate Trade Setup Notifications - newser.com
Vor Biopharma Inc. stock volume spike explainedWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Vor Biopharma Appoints New Chief Medical Officer - MSN
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - The Globe and Mail
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.44%
0.70%
자본화:
|
볼륨(24시간):